PRODUCTS SERVICES COMPANY CONTACT FAQ

Search Dictionary Mobile

Login

Mitomycin (Mitomycin-C)

Subscribe to Selected New Research on Mitomycin

5459 relevant articles (427 outcomes, 914 trials/studies) found for this Drug

Description: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.

Also Known As:

Mitomycin-C; Mutamycin; Ametycine; Mitocin-C; NSC-26980; Mitocin C; MitocinC; NSC 26980; NSC26980; Mitomycin C; Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 6-amino-8-(((aminocarbonyl)oxy)methyl)-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-, (1aS-(1aalpha,8beta,8aalpha,8balpha))-

Relationship Network

Drug Context: Research Results

-

Organic Chemicals: 42

-

-

Indolequinones: 8

-

-

Mitomycin: 5459

*

MFC protocol: 133

*

mitomycin C-dextran: 9

*

MiPE protocol: 6

*

mitomycin C-DNA adduct: 4

*

FAM protocol: 2

*

FIM protocol: 2

*

MAP protocol: 2

*

*

MMM protocol 2: 2

*

PMUE protocol 2: 2

*

AVM protocol: 1

*

FEM protocol: 1

*

MICE regimen: 1

*

mitomycin C-N(2)-deoxyguanosine adduct: 1

*

MV protocol 2: 1

*

BEMP protocol 2

*

*

*

*

*

*

*

desmethoxymitomycin A

*

*

*

F-FOMi protocol

*

FAM II protocol

*

*

*

*

*

*

*

*

*

FUDRAM protocol

*

*

*

*

MAC-VD protocol

*

*

Mallinson protocol

*

*

*

*

*

*

*

mito-MBD protocol

*

mitomycin C-anti-alpha-fetoprotein antibody conjugate

*

mitomycin C-immunoglobulin M antibody conjugate

*

*

*

*

*

*

MQF-OK protocol

*

MQF-OK-FT protocol

*

*

*

*

*

*

*

*

*

*

*

*

*

THP-FLPM protocol

*

*

*

-

Heterocyclic Compounds: 25

-

1-Ring Heterocyclic Compounds

-

-

-

Mitomycin: 5459

*

MFC protocol: 133

*

mitomycin C-dextran: 9

*

MiPE protocol: 6

*

mitomycin C-DNA adduct: 4

*

FAM protocol: 2

*

FIM protocol: 2

*

MAP protocol: 2

*

*

MMM protocol 2: 2

*

PMUE protocol 2: 2

*

AVM protocol: 1

*

FEM protocol: 1

*

MICE regimen: 1

*

mitomycin C-N(2)-deoxyguanosine adduct: 1

*

MV protocol 2: 1

*

BEMP protocol 2

*

*

*

*

*

*

*

desmethoxymitomycin A

*

*

*

F-FOMi protocol

*

FAM II protocol

*

*

*

*

*

*

*

*

*

FUDRAM protocol

*

*

*

*

MAC-VD protocol

*

*

Mallinson protocol

*

*

*

*

*

*

*

mito-MBD protocol

*

mitomycin C-anti-alpha-fetoprotein antibody conjugate

*

mitomycin C-immunoglobulin M antibody conjugate

*

*

*

*

*

*

MQF-OK protocol

*

MQF-OK-FT protocol

*

*

*

*

*

*

*

*

*

*

*

*

*

THP-FLPM protocol

*

*

*

-

2-Ring Heterocyclic Compounds

-

-

Indolequinones: 8

-

-

Mitomycin: 5459

*

MFC protocol: 133

*

mitomycin C-dextran: 9

*

MiPE protocol: 6

*

mitomycin C-DNA adduct: 4

*

FAM protocol: 2

*

FIM protocol: 2

*

MAP protocol: 2

*

*

MMM protocol 2: 2

*

PMUE protocol 2: 2

*

AVM protocol: 1

*

FEM protocol: 1

*

MICE regimen: 1

*

mitomycin C-N(2)-deoxyguanosine adduct: 1

*

MV protocol 2: 1

*

BEMP protocol 2

*

*

*

*

*

*

*

desmethoxymitomycin A

*

*

*

F-FOMi protocol

*

FAM II protocol

*

*

*

*

*

*

*

*

*

FUDRAM protocol

*

*

*

*

MAC-VD protocol

*

*

Mallinson protocol

*

*

*

*

*

*

*

mito-MBD protocol

*

mitomycin C-anti-alpha-fetoprotein antibody conjugate

*

mitomycin C-immunoglobulin M antibody conjugate

*

*

*

*

*

*

MQF-OK protocol

*

MQF-OK-FT protocol

*

*

*

*

*

*

*

*

*

*

*

*

*

THP-FLPM protocol

*

*

*